{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T07:18:13Z","timestamp":1783149493709,"version":"3.54.6"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018693","name":"Horizon Europe","doi-asserted-by":"publisher","award":["101046118"],"award-info":[{"award-number":["101046118"]}],"id":[{"id":"10.13039\/100018693","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.vaccine.2026.128781","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T12:03:22Z","timestamp":1780574602000},"page":"128781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multiple monovalent COVID-19 PHH-1V vaccine adaptations elicit homologous and cross-neutralizing antibody responses in mice"],"prefix":"10.1016","volume":"87","author":[{"given":"Alexandra","family":"Moros","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meritxell","family":"Deulofeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Rib\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c8lia","family":"Bosch-Ru\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ester","family":"Puigvert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laia","family":"Madrenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroa","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gran\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Barreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neus","family":"Cantari\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Prenafeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.vaccine.2026.128781_bb0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-2600(24)00179-6","article-title":"Estimated number of lives directly saved by COVID-19 vaccination programmes in the WHO European region from December, 2020, to March, 2023: a retrospective surveillance study","volume":"12","author":"Mesl\u00e9","year":"2024","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.vaccine.2026.128781_bb0010","article-title":"Efficacy and safety of COVID-19 vaccines","volume":"12","author":"Gra\u00f1a","year":"2022","journal-title":"Cochrane Database Syst. Rev. [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128781_bb0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.chom.2021.02.020","article-title":"The variant gambit: COVID-19\u2019s next move","volume":"29","author":"Plante","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128781_bb0020","first-page":"162","article-title":"SARS-CoV-2 variant biology: immune escape, transmission and fitness","volume":"21","author":"Carabelli","year":"2023","journal-title":"Nat. Rev. Microbiol. [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128781_bb0025","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41591-023-02220-y","article-title":"When to update COVID-19 vaccine composition","volume":"29","author":"Grant","year":"2023","journal-title":"Nat. Med. [Internet]"},{"key":"10.1016\/j.vaccine.2026.128781_bb0030","unstructured":"World Health Organization (WHO). Statement on the antigen composition of COVID-19 vaccines [Internet]. [cited 2025 Oct 7];Available from: https:\/\/www.who.int\/news\/item\/15-05-2025-statement-on-the-antigen-composition-of-covid-19-vaccines."},{"key":"10.1016\/j.vaccine.2026.128781_bb0035","unstructured":"European Medicines Agency (EMA). Bimervax. Summary of Product Characteristics [Internet]. 2025 [cited 2025 Oct 6];Available from: https:\/\/www.ema.europa.eu\/en\/documents\/product-information\/bimervax-epar-product-information_en.pdf."},{"key":"10.1016\/j.vaccine.2026.128781_bb0040","article-title":"Safety and immunogenicity of the protein-based PHH-1V compared to BNT162b2 as a heterologous SARS-CoV-2 booster vaccine in adults vaccinated against COVID-19: a multicentre, randomised, double-blind, non-inferiority phase IIb trial","volume":"28","author":"Corominas","year":"2023","journal-title":"Lancet Reg. Health Eur. [Internet]"},{"issue":"8","key":"10.1016\/j.vaccine.2026.128781_bb0045","article-title":"Omicron XBB.1.16-adapted vaccine for COVID-19: interim immunogenicity and safety clinical trial results","volume":"12","author":"L\u00f3pez Fern\u00e1ndez","year":"2024","journal-title":"Vaccines [Internet]"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128781_bb0050","article-title":"Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2","volume":"26","author":"Barreiro","year":"2023","journal-title":"iScience [Internet]"},{"issue":"35","key":"10.1016\/j.vaccine.2026.128781_bb0055","doi-asserted-by":"crossref","first-page":"5072","DOI":"10.1016\/j.vaccine.2023.07.008","article-title":"Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate","volume":"41","author":"Moros","year":"2023","journal-title":"Vaccine [Internet]"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128781_bb0060","article-title":"Antibody and B-cell responses to PHH-1V81 XBB.1.16-adapted SARS-CoV-2 booster vaccination are associated with variant neutralization","volume":"97","author":"Torres","year":"2025","journal-title":"J. Med. Virol. [Internet]"},{"issue":"9","key":"10.1016\/j.vaccine.2026.128781_bb0065","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.cell.2022.03.037","article-title":"Boosting with variant-matched or historical mRNA vaccines protects against Omicron infection in mice","volume":"185","author":"Ying","year":"2022","journal-title":"Cell [Internet]"},{"issue":"6666","key":"10.1016\/j.vaccine.2026.128781_bb0070","article-title":"Mapping SARS-CoV-2 antigenic relationships and serological responses","volume":"382","author":"Wilks","year":"2023","journal-title":"Science [Internet]"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128781_bb0075","doi-asserted-by":"crossref","first-page":"e374","DOI":"10.1016\/S1473-3099(25)00308-1","article-title":"Antigenic and virological characteristics of SARS-CoV-2 variants BA.3.2, XFG, and NB.1.8.1","volume":"25","author":"Guo","year":"2025","journal-title":"Lancet Infect. Dis. [Internet]"},{"issue":"4","key":"10.1016\/j.vaccine.2026.128781_bb0080","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.immuni.2024.02.017","article-title":"Immunological imprinting shapes the specificity of human antibody responses against SARS-CoV-2 variants","volume":"57","author":"Johnston","year":"2024","journal-title":"Immunity [Internet]"},{"issue":"3","key":"10.1016\/j.vaccine.2026.128781_bb0085","article-title":"Preclinical evaluation of a COVID-19 vaccine candidate based on a recombinant RBD fusion heterodimer of SARS-CoV-2","volume":"26","author":"Barreiro","year":"2023","journal-title":"iScience [Internet]"},{"issue":"7","key":"10.1016\/j.vaccine.2026.128781_bb0090","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107224","article-title":"Preclinical evaluation of PHH-1V vaccine candidate against SARS-CoV-2 in non-human primates","volume":"26","author":"Prenafeta","year":"2023","journal-title":"iScience"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X26005906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T06:46:30Z","timestamp":1783147590000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X26005906"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"alternative-id":["S0264410X26005906"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128781","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiple monovalent COVID-19 PHH-1V vaccine adaptations elicit homologous and cross-neutralizing antibody responses in mice","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2026.128781","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"128781"}}